The aim of this study is to review quantitative studies on women's experiences of consequences of false-positive screening mammography to assess the adequacy of the most frequently used instruments for measuring short-term and long-term psychological consequences.
INTRODUCTION
S pecificity of biennial screening mammography has been reported as 97%, I with positive predictive values of 9% and 17% for women aged 50-59 and 60-69, respectively.' Consequently, 10 out of 11 women in their fifties and five out of six in their sixties receiving an initial abnormal screening mammography do not have cancer. Thus, an abnormal screening mammography more often provides a false-positive than a true-positive result. In the UK, where three-yearly screening is offered to women aged 50-65, more than 50,000 women per year will receive a falsepositive mammography. ' The WHO recognise that cancer screening may have a negative affect on the target population." even when their 'Ten Commandments" for medical screening are adhered to. Gray and Austoker are more direct about the potential negative affects of screening: 'All screening programmes do harm; some also do good'! The ultimate damage caused by a screening program arises when healthy people die, either from diagnostic procedures or from medical interventions following a false-positive result. This has been reported after ovarian cancer screening." colorectal cancer screening." and lung cancer screening." In breast cancer screening, a case of suicide following receipt of a recall letter has been reported. 10 Mortality data indicate some benefits of cancer screening programs. It is possible to calculate financial burden and time consumption of screening on participants, medical practice and society. However, adverse effects such as psychosocial impact of a false screening result on the individual, are difficult to define and measure. II www.jmedscreen.com
The aim of this paper is to review quantitative studies on women's experiences of consequences of false-positive screening mammography to assess the adequacy of the most frequently used instruments for measuring short-term and long-term consequences.
METHODS
Relevant papers reporting quantitative studies on consequences of false-positive screening mammography were identified using MEDLINE, CINAHL, EMBASE and PsycInfo databases. Reference lists were manually searched for articles not identified through the electronic means. This process was continued until no more relevant papers were identified. Articles citing development and psychometric properties of the most frequently used measures were also retrieved. Finally, the review focused on studies that had used at least one of the most frequently used measures. The adequacy of measures was based on whether field-tests and psychometric analyses were appropriately conducted in the setting of false-positive screening mammography.
Fifteen studies investigated only short-term consequences of false-positive mammography i.e, up to three months after women were informed that they did not have breast cancer. 12-17.19-22.27.32.34-38 All reported adverse short-term consequences.
Seven studies measured short-term and long-term consequences (over more than three months).18. 23-26.28.29.31.33 They also consistently report adverse short-term consequences but results regarding long-term consequences are ambiguous. One study found that 15 % of the women receiving a false-positive mammography had measurable adverse consequences after six months:" Brett et al. found adverse long-term consequences at five, eleven, and 35 months follow Up;25.3] and three studies found no long-term consequences.IB. 26.33 Interpretation of results in two of the seven studies is unclear.v-" One study measured only long-term consequences and found that they were present after two years. 3D In the 23 different studies at least fifteen different measures have been used. Those used most often were the General Health Questionnaire (GHQ), the Hospital Anxiety and Depression Scale (HADS), the Psychological Consequences Questionnaire (PCQ) and the State-Trait Anxiety Inventory (STAl). One or more of these was used in 17 of the 23 studies. Table 1 summarises the results of the review. Item generation and scale development, scoring Brodersen, Thorsen, Cockburn system, psychometric properties and results of measuring consequences of false-positive screening mammography are reported for each of the four scales.
General Health Questionnaire (GHQ)
The GHQ is a self-administered questionnaire designed as a screening tool of psychiatric disorders in non-psychiatric clinical settings such as primary care or general medical out-patients." The original version, developed in 1972, contained 60 items covering four areas; depression, anxiety, objectively observable behaviour and hypochondriasis. The four dimensions arose mainly as a result of interviews conducted with 2460 non-hospitalised adults about aspects of adjustment and distress in 1960 52 and from interviews using the Cornell Medical Index":" with 120 residents of a Jewish housing project in 1965. Discussions were also conducted with experienced psychiatrists. 51 The anxiety scale used Fried and Lindemann's work of 'role-satisfaction'." Items were also taken from other scales and inventories and 30 items were developed specifically for the GHQ. 51 Items enquire about recent experience of symptoms or behaviour, with four response options (Tess than usual'. 'no more than usual', 'rather more than usual', and 'much more than usual') scored 0-1-2-3, as an adjectival scale on a con- Table 1 Quantitative studies on consequences of false positive mammography, reviews, and related papers. The articles are listed by year of publication and include two qualitative studies on consequences of false positive mammography. 49 tinuum with discrete responses. 56 Items are added to give a total score. 57 The measure can also be scored dichotomously, with '0' given for 'less than usual' and 'no more than usual', and 'I' for 'rather more than usual' and 'much more than usual'. 57 For the latter method, scores are added and if a person scores more than a given threshold they are classified as a 'case'." A 140-item version of the GHQ was published with the original 60 items. 51 Several different shorter versions have also been developed, namely GHQ-12, GHQ-28 and GHQ-30. 58 The 'case' thresholds vary with different versions. 58 The versions of the GHQ have been found to be reliable and valid, when subjected to traditional psychometric analysis such as test-retest reliability, internal, and concurrent validity in a variety of settings. 58 Two studies using item response theory (latent trait model) have tested the GHQ_12 59 and the GHQ-30 60 respectively. Both studies found a difference between positively and negatively orientated items, indicating that the GHQ may not be a unidimensional measure and perhaps it would be appropriate to split it up into a positive and a negative component.
Five of the reviewed studies used the GHQ-12 or GHQ-28 (Table 1) . 12.20.21.24.27 In one study only the GHQ-28 anxiety sub-scales was used'? and in another, the depression sub-scale was excluded from the GHQ-28. 27 An overall GHQ score has been calculated in three of the four studies, 12.20.27 while the other classified women as 'cases' or 'non-cases' . 21 Lowe et al. reported 'acceptable' Cronbach's alphas for the three subscales that were used from the GHQ-28,27 None of these studies have reported pre-testing or test-retest reliability in these settings.
Hospital Anxiety and Depression Scale (HADS)
The HADS is a patient-completed measure developed in 1983 to provide a reliable screening test for psychiatric disorders in patients in non-psychiatric hospital departmerits."! The HADS has fourteen items equally distributed in two subscales: depression and anxiety. The depression subscale was developed from the anhedonic state." as the authors argue that this responds well to antidepressant drug treatment. 62 The anxiety subscale was developed using modified items from the Hamilton Anxiety Scale (a rating scale for patients already diagnosed with neurotic anxiety)63.64 and the Present State Examination (a structured interview that assesses the present mental state of adult patients suffering from either neuroses or functional psychoses}." All items in the PSE were selected by psychiatrists and physicians.
Each item has four response options. Subjects select the option that best describes how they have been feeling over the previous week. These are scored 0-1-2-3, as an adjectival scale on a continuum with discrete responses. Items added to give a total score,"!
The HADS was first validated by comparing scores of 98 adult outpatients from a general medical clinic with ratings of clinicians blinded to patients' scores. These were used to determine score thresholds for 'non-cases' (score of seven or less), 'doubtful cases', (eight to 10) and 'cases' (11 or over). Secondly, a selection of patients were matched for age and gender with a 'normal' sample to test if the HADS scores were influenced by physical illness apart from mood disorders. The HADS has been used in a range of disease areas, with approximately 500 studies identified. Few have used a healthy person comparison group. Traditional psychometric assessments, mainly in studies that involve patients, have shown acceptable results." www.jmedscreen.com
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The HADS has been used in five of the reviewed studies (Table 1) . 14.24.26.32.33 These do not report pre-testing, testretest reliability, or analyses of internal consistency in these settings.
Psychological Consequences Questionnaire (PCQ)
The PCQ was developed in Australia in 1992 as a selfadministered measure of psychological consequences of screening mammography." Items encompassing emotional, social and physical domains were generated by reviewing published scales and research. Scales reviewed included the GHQ,51 the Sickness Impact Profile.t" a scale measuring whether screening programs cause morbid concern in the community." and a number of oncology quality of life measures.w" Interviews were also conducted with women attending screening and recall for further investigations after initial screening.
A sorting procedure showed high level of agreement between expert judges as to whether the postulated physical, social and emotional dimensions could be distinguished on the basis of item content. After pilot testing with other samples of women from the screening program, five items measuring emotional issues, four measuring physical and three measuring social issues were retained.
The questionnaire asks 'Over the last week how often have you experienced the following because of thoughts and feelings about breast cancer?' followed by the items. Response options are 'not at all', 'rarely', 'some of the time', and 'quite a lot of the time', scored from 0-3. Ratings for items within each dimension are added to give respective subscale scores. A higher score indicates greater dysfunction on that dimension. A pilot version of the PCQ was fieldtested in screening and recall clinics."? Items were tested for floor effect, ability to measure differences between groups of women and women's perceptions of ease of completion.
Responses of women at initial screening and assessment clinics were compared with ratings of a clinical interviewer, who was blinded to the PCQ score. The high level of agreement for each subscale was taken as an indicator for concurrent validity. Women's initial scores (obtained at the screening clinic) were compared with scores obtained during the recall visit. As scores varied in the predicted direction (higher scores, indicating greater dysfunction were found at the recall clinic) this was taken as evidence for construct validity.
The PCQ has been used in ten of the reviewed papers ( was completed by 220 women in a pilot study but data on concurrent validity were not reported." PCQ has been shown to be more sensitive than a 6-item short form of the STAI,23 the anxiety-trait scale of the STAI-Y,» and the GHQ-28 (excluding the depression subscale)." Three studies have performed factor analyses on the PCQ. Ong et al. found a single factor with an eigenvalue of 7.7, explaining 65% of the variance." Olsson et al. did not report their results, other than saying that the 'analysis did not suggest three underlying factors' . 28 Hislop et al. also do not report results but state that two dimensions were found." Cronbach's alpha values are presented in Table 2 .
State-Trait Anxiety Inventory (STAI)
The development of the STAI was initiated in 1964 with the purpose of producing 'an objective, self-reported research instrument that could be used to measure both state and trait anxiety in normal adults'." A large number of items from three widely used anxiety-trait scales'":" were reformulated so that each could be used as a measure of both anxiety-state and anxiety-trait." A number of tests were performed with college and university students, who were asked either to imagine hypothetical situations such as being relaxed or at being at an examination or by giving the questionnaire to the students in a period of non-examination and later in a period of examination. The result was a single scale, the Form-A of the STAI (STAI-A). Psycholinguistic problems led to the development of the STAI-X, which comprises a 20-item anxiety-trait scale (describing how the respondent feels in general) and a 20item anxiety-state scale (describing how the respondent feels at a particular moment).72 Further refinement after testing with high school students led to the 40 item STAI-Y, where weaker items from STAI-X were replaced either by equal or better psychometric items or by items that were more consistent with the concept of state and trait anxiety." There are four response options for each item in all the forms of the STAI, scored on a scale of 1-2-3-4 as an adjectival scale on a continuum with discrete responses." The higher score the higher the likelihood of either state or trait anxiety.P:??
Reliability and validity of the many forms of the STAI have been tested in several studies using traditional psychometric assessments. Results are acceptable." One study reports analyses based on item response theory on STAI-X data." Rasch analyses indicated that several items in both scales of the STAI-X 'produce misfit responses, share identical locations on the continuum, and do not produce equal units of measure'. Furthermore, the STAI-X was not accurate enough to differentiate the trait and state anxiety levels. Only ten items of the trait-scale and nine from the statescale were applicable, and there was a lack of items covering the measures of 'light' and 'severe' trait and state anxiety."
The STAI has been used in five of the reviewed papers but each study used a different version ( Table 1) 
DISCUSSION
The review has uncovered a number of issues with existing measures that cast doubts about their overall adequacy for measuring consequences of false-positive screening mammography.
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Firstly, the language used in items may not be relevant for current use. The GHQ, the HADS, and the STAI originate from the 1970s and 1980s and their item generation goes as far back as the 1950s. The language of a questionnaire must be kept up to date as the linguistic value of words and terms can take on new meanings over time." Both the wording of the items and the construct behind the measures could be different if the measures had been developed more recently.
Secondly, the content of items in some measures is not relevant for women attending for breast cancer screening and who may experience a false-positive mammography. The GHQ was developed to tap psychiatric disorders in nonpsychiatric clinical settings and the HADS to tap psychiatric disorders in non-psychiatric hospital departments. Middleaged healthy women participating in breast cancer screening and experiencing false-positive screening mammography can hardly be categorised as suffering from psychiatric disorders as such. Therefore, it is questionable whether the GHQ and the HADS can accurately capture the consequences of such an experience.
The STAI was developed to tap state and trait anxiety in normal adults. However, it is doubtful that the anxiety experienced by students before an examination equals the anxiety experienced by women threatened by breast cancer. Furthermore the lack of items in the STAI covering 'light' and 'severe' state and trait anxiety, shown by Rasch analyses." throws doubt on the STArs ability to capture the full construct of anxiety.
Moreover as the GHQ, the HADS, and the STAI cover psychiatric and psychological disorders in a broader sense, they may impose irrelevant items on women experiencing false-positive mammography. Streiner and Norman have warned that if items appear irrelevant, the respondent may object to them and omit them, irrespective of the instruments 'possibly superb psychometric properties'." Using more than one such measure could exacerbate the perception of irrelevance.
Thirdly, the variety of additional measures used in the 23 studies included in this review (Table 1) shows that the researchers acknowledge the necessity of supplementing the overall psychological and psychiatric measures to ensure content coverage. However, such variation makes it difficult to compare studies.P>" Response burden is another disadvantage. It would be preferable if the same level of information could be achieved by using a short questionnaire specifically developed to cover a target."
Despite the different questionnaires used, all studies found adverse short-term consequences of false-positive screening mammography. 12-24.26-29.32-38 This indicates at least some relevance of the batteries of measures chosen by the researchers. However, it does not indicate content coverage. Surprisingly, there is no evidence to suggest pre-testing of content relevance and coverage of the GHQ, the HADS and www.jmedscreen.com the STAI in any of the studies using these measures in this setting. If pre-testing had been conducted it might have shown that these measures do not cover all short-term and long-term consequences of false-positive mammography.
Fourthly, in all the reviewed studies little attention has been paid to the applicability of the measurements. Cockburn et at. first contributed to this discussion"? and developed a new questionnaire (PCQ) specific to the area. Sutton also addresses the applicability of measurement, and acknowledges that there could have been a different pattern of results in his study if a more specific instrument such as the PCQ had been used. The better sensitivity of the PCQ to detect psychological consequences of false-positive mammography compared with a six item short form of the STAV 3 the anxiety-trait scale of the STAI-y25 and the GHQ-28 exclusive the depression subscale." also suggests that the PCQ is more applicable to this setting than other instruments.
Fifthly, there are few assessments of the psychometric properties of instruments in the setting of false-positive consequences of screening mammography. Only two studies have reported analyses of internal consistency of three of four subscales of the GHQ-28 and an unknown version of the STAI in this setting. However, the relevance of adequate internal consistency is questionable when there has been no examination of the measure's content validity in the setting. In contrast, the consistently high levels of internal consistency of the PCQ that have been reported in various studies, along with the demonstrated content validity of the measure (at least for short-term consequences) gives further confidence of the adequacy of the PCQ for this setting.
Lastly, there is insufficient evidence that any of the current measures adequately describe the longer term consequences of receiving a false-positive result. This could explain the ambiguity of results in this area. The PCQ was used in two of the three studies that found some long-term consequences. It appears that the method of development of the PCQ ensured that at least some items are relevant for consideration of long-term consequences. However, development of PCQ items did not involve women for whom some time had passed since receiving their falsepositive result. Thus, there may be other relevant long-term consequences that have been missed. For example, Gram et al. report that one long-term consequence described by women after diagnostic surgery, was reduced sexual sensitivity of the breast. 13 Women also mention sexual consequences of false-positive mammography in a Canadian study about women's attitude to breast screening 80.
CONCLUSIONS
This review has revealed that the GHQ, the HADS and the STAI have problems with language, content relevance, and content coverage when these measures are used in studies of false-positive screening mammography. Given that the adequacy of these measures in this setting is doubtful. it is suggested that these instruments should not be used to measure psychological outcomes related to the consequences of any kind of cancer screening. It is worrying, therefore, that studies in colorectal screening are using these measures."
The review suggested that the PCQ is an adequate questionnaire for measuring short-term consequences of receiving a false-positive mammography and that the PCQ is preferable to other measures because of its higher sensitivity. However, the review also revealed that this instrument has some deficiencies when measuring long-term consequences of screening. There is little evidence that the PCQ is able to adequately detect all long-term consequences of screening mammography. The items were developed on women who were waiting to hear about their false-positive result, and did not include women who were told that their abnormal screening mammography was false. Women on early recall, women who had diagnostic surgery before being given a benign result and women whose false-positive result had occurred at some time in the past. were also not included.f This is an important issue that needs to be examined further in rigorously conducted qualitative studies that explore the range of issues for women viewing their false-positive results in the longer term, as a first step to develop a relevant measure in this setting. Until this is achieved, any conclusions about the long-term consequences of falsepositive results of screening mammography must remain tentative.
